Earlier this month, Juno Therapeutics, a pioneer in the field of treating cancer using genetically engineered cells, had to halt the development of its lead treatment after the death of three leukemia patients enrolled in the study. On September 12, 2016 By Admin Breaking News Post navigation Previous PostISIS Female Fighters Vow To Attack The WestNext PostTrump: We should debate with no moderator